Premium
REVACCINATION OF ADULTS AGAINST DIPHTHERIA I: RESPONSES AND REACTIONS TO DIFFERENT DOSES OF DIPHTHERIA TOXOID IN 30–70‐YEAR‐OLD PERSONS WITH LOW SERUM ANTITOXIN LEVELS
Author(s) -
Simonsen O.,
Kjeldsen K.,
Vendborg H.A.,
Heron I.
Publication year - 1986
Publication title -
acta pathologica microbiologica scandinavica series c: immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0108-0202
DOI - 10.1111/j.1699-0463.1986.tb02114.x
Subject(s) - antitoxin , vaccination , diphtheria , toxoid , medicine , diphtheria toxin , serology , immunology , corynebacterium diphtheriae , population , herd immunity , immunity , antibody , tetanus , pediatrics , biology , immune system , toxin , environmental health , microbiology and biotechnology
Studies of diphtheria antitoxin levels in serum from adult populations have indicated high frequencies of unprotected subjects. Serum from 351 randomly selected Danes between 30 and 70 years old has been assessed for antitoxin concentration; 123 persons among these, who had low antibody levels, received one vaccination with 2 Lf, 5 Lf or 12 Lf diphtheria toxoid. Side‐reactions were recorded, and antibody levels were studied 4 weeks later. Antitoxin concentration following vaccination increased markedly to above protective level in 83% of those vaccinated. Of subjects, who could document a complete primary vaccination series, only one receiving 2 Lf 31 years after primary vaccination did not attain protective antitoxin level. Minor local reactions only were recorded among subjects who did not respond serologically to vaccination. Frequencies of more pronounced reactions experienced by serologically responding subjects depended on dose and were 15%, 14% and 23% respectively. It was concluded that a single vaccination of the present adult Danish population will induce protective antibody levels so frequently that the effect of herd immunity will secure against epidemics if future diphtheria outbreaks are experienced. To secure individual protection, vaccination history and/or serological assessments have to be explored in order to decide whether a single vaccination is sufficient.